Development and validation of a sensitive method to quantify a poorly ionized drug, pocapavir, in C57BL/6 mouse plasma
The validated bioanalytical method is suitably equipped to quantify pocapavir while bolstering preclinical and potential applications for first-in-human (FIH) PK characterizations.
Authors
- Renmeng Liu (ORCID: https://orcid.org/0000-0001-7797-0994)
- Yurong Lai (ORCID: https://orcid.org/0000-0001-9505-333X)
- Ashley Davie
- Elaine To (ORCID: https://orcid.org/0000-0001-8556-2130)
Institutions
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- Bioanalysis
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1080/17576180.2025.2480533
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00